Possible explanations for this finding include that VCAM-1 may be a marker of progression independent of ILD and PAH disease manifestations, or that VCAM-1 may predict progression prior to these manifestations which, when established, progress in association with other biomarkers. The gene discussed is VCAM1; the disease is pulmonary arterial hypertension.